{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:39:48Z","timestamp":1792474788277,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03460-x","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:11:43Z","timestamp":1792473103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative transcriptomic and network analysis elucidates the multi-target molecular mechanisms of carboplatin in melanoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Mobina","family":"Shahriarizade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mehdi","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ahmadizad","family":"Firouzjaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"5","key":"3460_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA dermatology. 2022;158(5):495\u2013503.","journal-title":"JAMA dermatology"},{"key":"3460_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1268479","volume":"10","author":"S Waseh","year":"2023","unstructured":"Waseh S, Lee JB. Advances in melanoma: epidemiology, diagnosis, and prognosis. Front Med. 2023;10:1268479.","journal-title":"Front Med"},{"issue":"11","key":"3460_CR3","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.3390\/ijms25115794","volume":"25","author":"W Shalata","year":"2024","unstructured":"Shalata W, et al. Melanoma management: exploring staging, prognosis, and treatment innovations. Int J Mol Sci. 2024;25(11):5794.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3460_CR4","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/biomedicines12081851","volume":"12","author":"F Valdez-Salazar","year":"2024","unstructured":"Valdez-Salazar F, et al. Advances in melanoma: from genetic insights to therapeutic innovations. Biomedicines. 2024;12(8):1851.","journal-title":"Biomedicines"},{"issue":"1","key":"3460_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct Target therapy. 2025;10(1):57.","journal-title":"Signal Transduct Target therapy"},{"issue":"3","key":"3460_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40257-022-00681-4","volume":"23","author":"F Aroldi","year":"2022","unstructured":"Aroldi F, Middleton MR. Long-term outcomes of immune checkpoint inhibition in metastatic melanoma. Am J Clin Dermatol. 2022;23(3):331\u20138.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"3460_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.31557\/apjcb.2025.10.3.759-768","volume":"10","author":"R Shatnawi","year":"2025","unstructured":"Shatnawi R, et al. Advances in Uveal Melanoma: From Molecular Pathogenesis to Precision Diagnostics and Personalized Therapies: Narrative Overview. Asian Pac J Cancer Biology. 2025;10(3):759\u201368.","journal-title":"Asian Pac J Cancer Biology"},{"issue":"3","key":"3460_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/proteomes12030025","volume":"12","author":"R Vitorino","year":"2024","unstructured":"Vitorino R. Transforming clinical research: the power of high-throughput omics integration. Proteomes. 2024;12(3):25.","journal-title":"Proteomes"},{"key":"3460_CR9","volume":"45","author":"A Ahmadizad Firouzjaei","year":"2026","unstructured":"Ahmadizad Firouzjaei A, Aghaee-Bakhtiari SH, Mohammadi-Yeganeh S. Regulation of ferroptosis in colorectal cancer through therapeutic modulation and miRNA targeting. Biochem Biophys Rep. 2026;45:102444.","journal-title":"Biochem Biophys Rep"},{"issue":"4","key":"3460_CR10","doi-asserted-by":"publisher","first-page":"e0269324","DOI":"10.1371\/journal.pone.0269324","volume":"18","author":"I Orlow","year":"2023","unstructured":"Orlow I, et al. InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. PLoS ONE. 2023;18(4):e0269324.","journal-title":"PLoS ONE"},{"key":"3460_CR11","unstructured":"Park Y. Machine learning-based approaches to integrate heterogeneous data for biological knowledge transfer. 2024."},{"issue":"5","key":"3460_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41576-023-00679-6","volume":"25","author":"TG Brooks","year":"2024","unstructured":"Brooks TG, et al. Challenges and best practices in omics benchmarking. Nat Rev Genet. 2024;25(5):326\u201339.","journal-title":"Nat Rev Genet"},{"key":"3460_CR13","doi-asserted-by":"publisher","DOI":"10.5530\/ijpi.20250268","author":"RM Alghamdi","year":"2025","unstructured":"Alghamdi RM. Multi-dataset identification and validation of new gene expression signatures: insights into matrix remodeling pathways in NSCLC. Int J Pharm Investig. 2025. . https:\/\/doi.org\/10.5530\/ijpi.20250268","journal-title":"Int J Pharm Investig"},{"key":"3460_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-38424-8","author":"L Zhou","year":"2026","unstructured":"Zhou L, et al. Integrated multi-dataset screening to predict prognosis and identify immunotherapy gene targets in hepatocellular carcinoma patients. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-026-38424-8.","journal-title":"Sci Rep"},{"key":"3460_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-28771-3","author":"MM Madbouly","year":"2025","unstructured":"Madbouly MM, Darwish SM, El-Shoafy NA. Biodata-centric cardiovascular disease prediction using multi-objective genetic algorithm-driven deep ensembles. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-28771-3.","journal-title":"Sci Rep"},{"issue":"1","key":"3460_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13721-024-00467-0","volume":"13","author":"T Rout","year":"2024","unstructured":"Rout T, Mohapatra A, Kar M. A systematic review of graph-based explorations of PPI networks: methods, resources, and best practices. Netw Model Anal Health Inf Bioinf. 2024;13(1):29.","journal-title":"Netw Model Anal Health Inf Bioinf"},{"key":"3460_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/978-981-95-2525-6_30","volume-title":"Artificial Intelligence for Drug Design","author":"T Tian","year":"2026","unstructured":"Tian T. Network Pharmacology and Drug Repurposing. In: Artificial Intelligence for Drug Design. Springer; 2026. p. 449\u201372."},{"key":"3460_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2025.102053","author":"MJ Bazyari","year":"2025","unstructured":"Bazyari MJ, et al. Exploiting network-based drug repositioning to target metastasis in colorectal cancer: in-silico prediction and in-vitro evidence. Mol Cell Probes. 2025. . https:\/\/doi.org\/10.1016\/j.mcp.2025.102053","journal-title":"Mol Cell Probes"},{"issue":"9","key":"3460_CR19","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/pharmaceutics17091186","volume":"17","author":"X Bi","year":"2025","unstructured":"Bi X, et al. Machine learning for multi-target drug discovery: challenges and opportunities in systems pharmacology. Pharmaceutics. 2025;17(9):1186.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3460_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.30574\/ijsra.2023.8.1.0189","volume":"8","author":"H Ali","year":"2023","unstructured":"Ali H. Artificial intelligence in multi-omics data integration: Advancing precision medicine, biomarker discovery and genomic-driven disease interventions. Int J Sci Res Arch. 2023;8(1):1012\u201330.","journal-title":"Int J Sci Res Arch"},{"issue":"1","key":"3460_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13040-025-00442-z","volume":"18","author":"W Jiang","year":"2025","unstructured":"Jiang W, et al. Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BioData Min. 2025;18(1):27.","journal-title":"BioData Min"},{"key":"3460_CR22","unstructured":"Tonella L. Advancing melanoma treatment: personalized medicine through molecular targeting. Construction and analysis of a Comprehensive clinical database and identification of biomarkers for adjuvant therapy in stage III melanoma. 2025."},{"issue":"10","key":"3460_CR23","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/ph18101536","volume":"18","author":"JD Ripa","year":"2025","unstructured":"Ripa JD, et al. From AI-Assisted In Silico Computational Design to Preclinical In Vivo Models: A Multi-Platform Approach to Small Molecule Anti-IBD Drug Discovery. Pharmaceuticals. 2025;18(10):1536.","journal-title":"Pharmaceuticals"},{"key":"3460_CR24","unstructured":"Wang T et al. From in silico to in vitro: a comprehensive guide to validating bioinformatics findings. arXiv preprint arXiv:2502.03478, 2025."},{"issue":"3","key":"3460_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/jmp6030020","volume":"6","author":"G Molla","year":"2025","unstructured":"Molla G, Bitew M. The future of cancer diagnosis and treatment: Unlocking the power of biomarkers and personalized molecular-targeted therapies. J Mol Pathol. 2025;6(3):20.","journal-title":"J Mol Pathol"},{"issue":"1","key":"3460_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13048-022-01003-2","volume":"15","author":"L Han","year":"2022","unstructured":"Han L, et al. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases. J ovarian Res. 2022;15(1):75.","journal-title":"J ovarian Res"},{"key":"3460_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-981-96-2763-9_13","volume-title":"Cell Signaling Pathways and Their Therapeutic Implication in Cancers","author":"AN Sheikh","year":"2025","unstructured":"Sheikh AN. Role of Signaling Pathways Regulating Genomic Stability in Cancer. In: Cell Signaling Pathways and Their Therapeutic Implication in Cancers. Springer; 2025. p. 395\u2013435."},{"key":"3460_CR28","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096366956250314043513","author":"H Marwah","year":"2025","unstructured":"Marwah H, Dewangan HK. Synergistic targeting of EGFR, ESR1, BCL2, and TP53 pathways: a multi-pronged approach for advanced breast cancer therapy. Curr Cancer Drug Targets. 2025. https:\/\/doi.org\/10.2174\/0115680096366956250314043513","journal-title":"Curr Cancer Drug Targets"},{"issue":"9","key":"3460_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.46883\/2025.25921052","volume":"39","author":"A Shahiwala","year":"2025","unstructured":"ShahiwalaA. Convergent and divergent signaling pathways in cancer: A dual-axis model for adaptive precision oncology. Oncol (Williston Park). 2025;39(9):386\u201393. https:\/\/doi.org\/10.46883\/2025.25921052","journal-title":"Oncol (Williston Park)"},{"issue":"3","key":"3460_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/cancers14030664","volume":"14","author":"A Karagiannakos","year":"2022","unstructured":"Karagiannakos A, et al. Targeting oncogenic pathways in the era of personalized oncology: a systemic analysis reveals highly mutated signaling pathways in cancer patients and potential therapeutic targets. Cancers. 2022;14(3):664.","journal-title":"Cancers"},{"key":"3460_CR31","doi-asserted-by":"publisher","unstructured":"Gupta S et al. Computational Approaches for Drug Target Identification, in Bioinformatics, Computational Chemistry, and AI in Drug Innovation. CRC Press; 2026. pp. 119\u201336. https:\/\/doi.org\/10.1201\/9781003464679-10","DOI":"10.1201\/9781003464679-10"},{"key":"3460_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155258","volume":"256","author":"AA Firouzjaei","year":"2024","unstructured":"Firouzjaei AA, et al. Identification and analysis of the molecular targets of statins in colorectal cancer. Pathol Res Pract. 2024;256:155258.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"3460_CR33","doi-asserted-by":"publisher","first-page":"40714","DOI":"10.1038\/s41598-025-24625-0","volume":"15","author":"E Fadhal","year":"2025","unstructured":"Fadhal E. Network centric identification of PI3K\/Akt hub proteins as key oncogenic drivers and therapeutic targets. Sci Rep. 2025;15(1):40714.","journal-title":"Sci Rep"},{"issue":"12","key":"3460_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ph15121475","volume":"15","author":"KN Venugopala","year":"2022","unstructured":"Venugopala KN. Targeting the DNA damage response machinery for lung cancer treatment. Pharmaceuticals. 2022;15(12):1475.","journal-title":"Pharmaceuticals"},{"issue":"12","key":"3460_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126444","volume":"25","author":"Y Feng","year":"2024","unstructured":"Feng Y, et al. Exploring the complexity and promise of tumor immunotherapy in drug development. Int J Mol Sci. 2024;25(12):6444.","journal-title":"Int J Mol Sci"},{"key":"3460_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08287-4","author":"X Zheng","year":"2025","unstructured":"Zheng X, et al. AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling. Cell Death Dis. 2025. https:\/\/doi.org\/10.1038\/s41419-025-08287-4.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3460_CR37","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/molecules31030543","volume":"31","author":"MX Dur\u00e1n-Maldonado","year":"2026","unstructured":"Dur\u00e1n-Maldonado MX, et al. Bacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model. Molecules. 2026;31(3):543.","journal-title":"Molecules"},{"issue":"4","key":"3460_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1753-0407.13252","volume":"14","author":"I Camaya","year":"2022","unstructured":"Camaya I, Donnelly S, O\u2019Brien B. Targeting the PI3K\/Akt signaling pathway in pancreatic \u03b2-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes. J diabetes. 2022;14(4):247\u201360.","journal-title":"J diabetes"},{"issue":"11","key":"3460_CR39","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/pharmaceutics17111421","volume":"17","author":"A Berral-Gonz\u00e1lez","year":"2025","unstructured":"Berral-Gonz\u00e1lez A, et al. Pharmacogenomic Drug\u2013Target Network Analysis Reveals Similarity Profiles Among FDA\u2013Approved Cancer Drugs. Pharmaceutics. 2025;17(11):1421.","journal-title":"Pharmaceutics"},{"issue":"24","key":"3460_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417488","volume":"24","author":"E Manousakis","year":"2023","unstructured":"Manousakis E, et al. CDKN1A\/p21 in breast cancer: part of the problem, or part of the solution? Int J Mol Sci. 2023;24(24):17488.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"3460_CR41","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.3390\/ijms23137058","volume":"23","author":"G Ticli","year":"2022","unstructured":"Ticli G, et al. Revisiting the function of p21CDKN1A in DNA repair: the influence of protein interactions and stability. Int J Mol Sci. 2022;23(13):7058.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3460_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/jox16010009","volume":"16","author":"M Cecati","year":"2026","unstructured":"Cecati M, et al. Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology. J Xenobiotics. 2026;16(1):9.","journal-title":"J Xenobiotics"},{"issue":"9","key":"3460_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/jclinpath-2021-208008","volume":"75","author":"FA Ince","year":"2022","unstructured":"Ince FA, Shariev A, Dixon K. PTEN as a target in melanoma. J Clin Pathol. 2022;75(9):581\u20134.","journal-title":"J Clin Pathol"},{"issue":"1","key":"3460_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12964-024-01860-y","volume":"22","author":"J Mahin","year":"2024","unstructured":"Mahin J, et al. cGAS\/STING in skin melanoma: from molecular mechanisms to therapeutics. Cell Communication Signal. 2024;22(1):553.","journal-title":"Cell Communication Signal"},{"issue":"8","key":"3460_CR45","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.3390\/ijms26083475","volume":"26","author":"M Wang","year":"2025","unstructured":"Wang M, et al. Cell death modalities in therapy of melanoma. Int J Mol Sci. 2025;26(8):3475.","journal-title":"Int J Mol Sci"},{"key":"3460_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2025.03.005","volume":"294\u2013295","author":"T Okamoto","year":"2025","unstructured":"Okamoto T, et al. Immune prognostic model for glioblastoma based on the ssGSEA enrichment score. Cancer Genet. 2025;294\u2013295:32\u201341.","journal-title":"Cancer Genet"},{"key":"3460_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cancergen.2025.09.010","volume":"298\u2013299","author":"Y Wei","year":"2025","unstructured":"Wei Y, et al. Molecular mechanisms underlying the oncogenic and tumor-suppressive roles of ZHX2 in cancers. Cancer Genet. 2025;298\u2013299:128\u201332.","journal-title":"Cancer Genet"},{"key":"3460_CR48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cancergen.2025.07.009","volume":"296\u2013297","author":"Q Wei","year":"2025","unstructured":"Wei Q, et al. The mechanism of lncRNA SSTR5-AS1 promoting ferroptosis resistance and immune escape in ovarian cancer cells by recruiting STAT3 to regulate SLC7A11 expression. Cancer Genet. 2025;296\u2013297:172\u201381.","journal-title":"Cancer Genet"},{"key":"3460_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cancergen.2025.11.006","volume":"298\u2013299","author":"Z Fang","year":"2025","unstructured":"Fang Z, et al. FBXL16 regulates TAMs recruitment by mediating cytokine release in gliomas. Cancer Genet. 2025;298\u2013299:285\u201394.","journal-title":"Cancer Genet"},{"key":"3460_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, et al. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol. 2026;17:1790936.","journal-title":"Front Immunol"},{"key":"3460_CR51","doi-asserted-by":"publisher","unstructured":"Luo H et al. CAMM: Confidence-Aligned Multiview Multimodal Fusion for Brain Disorders Prediction With Imaging Transcriptomics. IEEE J Biomed Health Inf, 2026. Pp. 1-13. https:\/\/doi.org\/10.1109\/JBHI.2026.3672862","DOI":"10.1109\/JBHI.2026.3672862"},{"issue":"4","key":"3460_CR52","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00335-025-10166-4","volume":"36","author":"Z Liu","year":"2025","unstructured":"Liu Z, et al. Multi-omics dissection of RAD21-PON1 axis reveals metabolic-immune crosstalk and prognostic significance in hepatocellular carcinoma. Mamm Genome. 2025;36(4):1291\u2013315.","journal-title":"Mamm Genome"},{"issue":"1","key":"3460_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10000-3","volume":"24","author":"Z Liu","year":"2024","unstructured":"Liu Z, et al. Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells. BMC Infect Dis. 2024;24(1):1099.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"3460_CR54","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00204-024-03910-3","volume":"99","author":"C Zhang","year":"2025","unstructured":"Zhang C, et al. A transcriptome-wide association study integrating multi-omics bioinformatics and Mendelian randomization reveals the prognostic value of ADAMDEC1 in colon cancer. Arch Toxicol. 2025;99(2):645\u201365.","journal-title":"Arch Toxicol"},{"issue":"1","key":"3460_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12879-024-09176-5","volume":"24","author":"K Li","year":"2024","unstructured":"Li K, et al. Causal effects of gut microbiome on HIV infection: a two-sample mendelian randomization analysis. BMC Infect Dis. 2024;24(1):280.","journal-title":"BMC Infect Dis"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03460-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:11:45Z","timestamp":1792473105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03460-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3460"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03460-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. This study did not require ethical approval, and consent to participate was not applicable. All authors approved the final version of the manuscript and consent to its publication. Data supporting the findings of this work are available from the corresponding author upon reasonable request. No external funding was received for this study.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent to participate was not applicable, as this study did not involve human subjects.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to the publication of this manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is derived from the core concepts and investigations conducted within project code 4032741, carried out under the ethical approval IR.MUMS.IRH.REC.1405.015, issued by the Ethics Committee of Mashhad University of Medical Sciences, Mashhad, Iran. The study did not involve any human participants or animal subjects.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"349"}}